microdosing compounded tirzepatide Microdose Women's Microdosing & Weight Maintenance

While individual experiences vary, clinical studies and patient feedback provide some helpful guidelines

[1,4] MECHANISM OF ACTION Semaglutide is a GLP-1 receptor agonist [Figure 1] that enhances insulin secretion while reducing glucagon release

Wegovy 7.2mg is not yet available on the NHS

One clinical trial took a look at the extent of total body weight lost with consistent use of semaglutide over time and showed that at 68 weeks of consistent semaglutide use [2]: 69.1% of participants had lost more than 10% of their total body weight 50.5% of participants had lost more than 15% of their total body weight Overall, 1 in 3 participants lost at least 20% of their total body weight The average total body weight loss was 14.9% Most importantly, while clinical trials and studies show just how effective semaglutide is for losing weight, using this medication also helps improve health-related quality of life in many other ways [3]

[ [PMID: 36216945] et al

Metabolism of GLP-1 and the therapeutic actions of long-lasting agonists GLP-1 has an extremely short half-life once released in the plasma, ranging from 211 minutes(Deacon et al., 1995